AAAAAA
Results: 26-50/73
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
STRYCKMANS P
Citation: L. Lagneaux et al., B-CHRONIC LYMPHOCYTIC LEUKEMIC-CELLS ARE PROTECTED FROM SPONTANEOUS APOPTOSIS AFTER ADHESION TO BONE-MARROW STROMA - ROLE OF BETA-1 AND BETA-2 INTEGRINS, Blood, 90(10), 1997, pp. 2326-2326
Authors:
KORNREICH A
LAMBERMONT M
FEREMANS W
BRON D
PRADIER O
GOLDMAN M
TOUNGOUZ M
Citation: A. Kornreich et al., DECREASED IFN-GAMMA SECRETION BY T-LYMPHOCYTES IN LEUKAPHERESIS AFTERG-CSF MOBILIZATION OF HEALTHY DONORS, Blood, 90(10), 1997, pp. 2512-2512
Authors:
DEBRUYN C
STRYCKMANS P
BRON D
MASSY M
BERNIER M
DEHEMPTINNE D
DELFORGE A
Citation: C. Debruyn et al., CELL-CYCLE STATUS AND KINETICS OF CD34(-BLOOD AND BONE-MARROW() SUBPOPULATIONS FROM CORD), Experimental hematology, 24(9), 1996, pp. 52-52
Authors:
LAGNEAUX L
DELFORGE A
BOSMANS E
BRUGGEMAN C
SNOECK R
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., RECOMBINANT PROTEINS OF HUMAN CYTOMEGALOVIRUS (GB, PP65, AND PP150) INCREASE CONSTITUTIVE PRODUCTION OF IL-6 AND LIF BY BONE-MARROW STROMALCELLS, Experimental hematology, 24(9), 1996, pp. 508-508
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
DORVAL C
MASSY M
BERNIER M
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC LEUKEMIC (CLL) B-LYMPHOCYTES ADHERING TO BONE-MARROW STROMAL CELLS ARE PROTECTED FROM APOPTOSIS, Experimental hematology, 24(9), 1996, pp. 515-515
Authors:
LAGNEAUX L
DELFORGE A
SNOECK R
BOSMANS E
SCHOLS D
DECLERCY E
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., IMBALANCE IN PRODUCTION OF CYTOKINES BY BONE-MARROW STROMAL CELLS FOLLOWING CYTOMEGALOVIRUS-INFECTION, The Journal of infectious diseases, 174(5), 1996, pp. 913-919
Authors:
BEGUIN Y
LAMPERTZ S
BRON D
FILLET G
Citation: Y. Beguin et al., SERUM ERYTHROPOIETIN IN CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 93(1), 1996, pp. 154-156
Authors:
SARFATI M
CHEVRET S
CHASTANG C
BIRON G
STRYCKMANS P
DELESPESSE G
BINET JL
MERLEBERAL H
BRON D
Citation: M. Sarfati et al., PROGNOSTIC IMPORTANCE OF SERUM-SOLUBLE CD23 LEVEL IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 88(11), 1996, pp. 4259-4264
Authors:
DEBRUYN C
DELFORGE A
BRON D
BERNIER M
STRYCKMANS P
Citation: C. Debruyn et al., CELL-CYCLE STATUS AND KINETICS OF CD34(-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD() SUBPOPULATIONS FROM UMBILICAL), Blood, 88(10), 1996, pp. 3130-3130
Authors:
LAGNEAUX L
DELFORGE A
BOSMANS E
BRUGGEMAN C
SNOECK R
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., DISTURBANCE OF CYTOKINE RELEASE BY BONE-MARROW STROMAL CELLS AFTER EXPOSURE TO RECOMBINANT PROTEINS OF HU CMV (GB, PP65 AND PP150), Blood, 88(10), 1996, pp. 3236-3236
Authors:
TRENSCHEL R
BERNIER M
MASSY M
MAEREVOET M
DEHEMRICOURT EL
DELFORGE A
BADJOU R
STRYCKMANS P
BRON D
Citation: R. Trenschel et al., MYELOID AND LYMPHOID RECOVERY AFTER ALLOGENEIC RELATED, UNRELATED BONE-MARROW AND RELATED PERIPHERAL STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 3838-3838
Authors:
BEGUIN Y
VERMYLEN C
NOENS L
FERRANT A
SCHOTS R
DOYEN C
BRON D
BERNEMAN Z
FERSTER A
BOOGAERTS M
Citation: Y. Beguin et al., THE BELGIAN EXPERIENCE IN UNRELATED DONOR BONE-MARROW TRANSPLANTATION- PROGNOSTIC VALUE OF A PATIENT-BASED AND DISEASE-BASED SCORING SYSTEM, Blood, 88(10), 1996, pp. 1047-1047
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
DORVAL C
BERNIER M
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CD19(-MARROW STROMAL CELLS()CD5(+)LYMPHOCYTES BUT NOT NORMAL CD19(+)CD5(+) LYMPHOCYTES ARE RESCUED FROMAPOPTOSIS BY CONTACT WITH BONE), Blood, 88(10), 1996, pp. 1175-1175
Authors:
LAGNEAUX L
DELFORGE A
SNOECK R
BOSMANS E
MOREAU JF
TAUPIN JL
DECLERCQ E
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., HUMAN CYTOMEGALOVIRUS INCREASES CONSTITUTIVE PRODUCTION OF INTERLEUKIN-6 AND LEUKEMIA INHIBITORY FACTOR BY BONE-MARROW STROMAL CELLS, Blood, 87(1), 1996, pp. 59-66
Authors:
DEBRUYN C
DELFORGE A
BRON D
BERNIER M
MASSY M
LEY P
DEHEMPTINNE D
STRYCKMANS P
Citation: C. Debruyn et al., COMPARISON OF THE COEXPRESSION OF CD38, CD33 AND HLA-DR ANTIGENS ON CD34(-BLOOD AND BONE-MARROW() PURIFIED CELLS FROM HUMAN CORD), Stem cells, 13(3), 1995, pp. 281-288
Authors:
BERNIER M
MASSY M
DELEEUW N
BRON D
DEBUSSCHER L
STRYCKMANS P
Citation: M. Bernier et al., IMMUNOLOGICAL DEFINITION OF ACUTE MINIMALLY DIFFERENTIATED MYELOID-LEUKEMIA (MO) AND ACUTE UNDIFFERENTIATED LEUKEMIA (AUL), Leukemia & lymphoma, 18, 1995, pp. 13-17
Authors:
LAGNEAUX L
DELFORGE A
BRON D
BOSMANS E
STRYCKMANS P
Citation: L. Lagneaux et al., COMPARATIVE-ANALYSIS OF CYTOKINES RELEASED BY BONE-MARROW STROMAL CELLS FROM NORMAL DONORS AND B-CELL CHRONIC LYMPHOCYTIC LEUKEMIC PATIENTS, Leukemia & lymphoma, 17(1-2), 1995, pp. 127-133
Authors:
DELFORGE A
LAGNEAUX L
DJEUDJANG J
BRON D
STRYCKMANS P
Citation: A. Delforge et al., THE TETRAPEPTIDE ACSDKP (SERASPENIDE) REDUCES THE IN-VITRO TOXICITY OF MAFOSFAMIDE (ASTA-Z) TO BONE-MARROW STROMAL CELLS, Experimental hematology, 23(8), 1995, pp. 769-769
Authors:
DEBRUYN C
VANDERBEQUE A
BRON D
VEKEMANS J
STRYCKMANS P
DELFORGE A
Citation: C. Debruyn et al., RECOMBINANT HUMAN INTERLEUKIN-11 - ITS IN-VIVO EFFECTS ON CORD-BLOOD AND BONE-MARROW CLONOGENIC PROGENITOR CELLS, Experimental hematology, 23(8), 1995, pp. 870-870
Authors:
PHILIP T
GUGLIELMI C
HAGENBEEK A
SOMERS R
VANDERLELIE H
BRON D
SONNEVELD P
GISSELBRECHT C
CAHN JY
HAROUSSEAU JL
COIFFIER B
BIRON P
MANDELLI F
CHAUVIN F
Citation: T. Philip et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS COMPARED WITH SALVAGE CHEMOTHERAPY IN RELAPSES OF CHEMOTHERAPY-SENSITIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 333(23), 1995, pp. 1540-1545
Authors:
CAZZOLA M
MESSINGER D
BATTISTEL V
BRON D
CIMINO R
ENLLERZIEGLER L
ESSERS U
GREIL R
GROSSI A
JAGER G
LEMEVEL A
NAJMAN A
SILINGARDI V
SPRIANO M
VANHOOF A
EHMER B
Citation: M. Cazzola et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA OR NON-HODGKINS-LYMPHOMA - DOSE-FINDING AND IDENTIFICATION OF PREDICTORS OF RESPONSE, Blood, 86(12), 1995, pp. 4446-4453
Authors:
HAGENBEEK A
GUGLIELMI C
CHAUVIN F
VANDERLELY J
BRON D
SONNEVELD P
GISSELBRECHT C
CAHN JY
HAROUSSEAU JL
COIFFIER B
BIRON P
SOMERS R
PHILIP T
Citation: A. Hagenbeek et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CONVENTIONAL CHEMOTHERAPY IN PATIENTS WITH RELAPSED DIFFUSE NONHODGKINS LYMPHOMA - RESULTS FROM A PROSPECTIVE, RANDOMIZED PHASE-III CLINICAL-TRIAL IN 216 PATIENTS (THE PARMA STUDY), Blood, 86(10), 1995, pp. 1817-1817
Authors:
MERLEBERAL H
CHEVRET S
BIRON G
STRYCKMANS P
CHASTANG C
DELESPESSE G
BINET JL
BRON D
SARFATI M
Citation: H. Merleberal et al., PROGNOSTIC IMPORTANCE OF SERUM-SOLUBLE CD23 LEVEL IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 2413-2413
Authors:
VANHOOF A
BOSLY A
BOOGAERTS M
NOENS L
BRON D
FILLET G
DEBOCK R
SCHOTS R
FERRANT A
Citation: A. Vanhoof et al., EFFICACY AND TOLERABILITY OF RH-INTERLEUKIN-3 AFTER CHEMOTHERAPY IN PATIENTS WITH RELAPSED HODGKINS AND NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 3288-3288
Authors:
BLEIBERG H
BODY JJ
BRON D
CULLUS D
GERAIN J
LOSSIGNOL D
RAZAVI D
SCULIER JP
THIRION M
KLASTERSKY J
Citation: H. Bleiberg et al., SUPPORTIVE CARE IN CANCER-PATIENTS, Bailliere's clinical infectious diseases, 1(3), 1994, pp. 601-629